2m 2m 2m 2m 2m 2m 2m
Omeros (OMER)
NASDAQ
$10.15-$0.11 (-1.07%)
Price as of Jun 03, 2026 6:42 PM EDT- $799.0MMarket Cap
- 226.75%1-Year Change
- BiotechnologyIndustry
Omeros (OMER)
$10.15-$0.11 (-1.07%)
OMER | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.26 | ||
Change | -$0.46 (-4.29%) | ||
Open | $10.54 | ||
High | $10.65 | ||
Low | $10.21 | ||
Previous Close | $10.72 | ||
Volume | 2,441,041 | ||
30-Day Average Volume | 1,669,459 | ||
1-Week Change | -11.93% | ||
1-Month Change | -31.87% | ||
1-Year Change | 226.75% | ||
3-Year Change | 38.46% | ||
5-Year Change | -35.19% | ||
Fundamentals | |||
Shares Outstanding | 72.4M | ||
Total Assets | $286.2M | ||
Market Cap | $799.0M | ||
Enterprise Value | $901.3M | ||
Period: QTR TTM FY | |||
Revenue | $9.9M | ||
Net Income | $56.1M | ||
Free Cash Flow | -$14.5M | ||
EBIT | $57.5M | ||
EBITDA | $57.8M | ||
Net Working Capital | $120.9M | ||
EPS | $0.62 | ||
Enterprise Value/EBITDA | 16 | ||
Enterprise Value/Revenue | 91 | ||
P/B | -13 | ||
P/E | 18 | ||
PEG | -0 | ||
Price/Free Cash Flow | -55 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue